Covered recipient · General Payments record
CAMRYN P PREJEAN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Surgical
General Payments · PY2021–2025
$1,276.07
- Reported across 61 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $241.44 | 10 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DAVOL INC. | $60.10 | 2 |
| Lilly USA, LLC | $43.75 | 2 |
| Dilon Technologies, Inc. | $38.90 | 1 |
| HISTOSONICS, INC. | $22.96 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $20.60 | 1 |
| Pacira Pharmaceuticals Incorporated | $19.81 | 1 |
| ALCRESTA THERAPEUTICS, INC. | $19.68 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $15.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aimmune Therapeutics, Inc. | $20.60 | 02/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249694243 | CMS |
| Alcresta Therapeutics, Inc. | $19.68 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234912153 | CMS |
| Davol Inc. | $25.25 | 02/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232218846 | CMS |
| Davol Inc. | $34.85 | 10/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232218866 | CMS |
| Dilon Technologies, Inc. | $38.90 | 05/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1221004992 | CMS |
| HISTOSONICS, INC. | $22.96 | 06/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233992214 | CMS |
| Lilly USA, LLC | $22.34 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187009246 | CMS |
| Lilly USA, LLC | $21.41 | 03/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187009248 | CMS |
| Pacira Pharmaceuticals Incorporated | $19.81 | 12/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250292352 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $15.64 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1213916218 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.